34 Genetic elimination of dengue vector mosquitoes. de Valdez MRW et al. (2011). PNAS 108: 4772-4775.
http://www.pnas.org/content/108/12/4772.abstract
33 Mutations in the RNA Granule Component TDRD7 Cause Cataract and Glaucoma. Lachke SK et al. (2011). Science 331: 1571-1576.
http://www.sciencemag.org/content/331/6024/1571.abstract
32 miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes.
Qian L et al. (2011). JEM 208:549-560.
http://jem.rupress.org/content/208/3/549.abstract
31 Mitochondrial reactive oxygen species drive proinflammatory cytokine production.
Naik E and Dixit VM. (2011). J. Exp. Med. 208: 417-420.
http://jem.rupress.org/content/208/3/417.abstract
30 Cardiac myosin activation: A potential therapeutic approach for systolic heart failure.
Malik FI. et al. (2011). Science 331:1439-1443.
http://www.sciencemag.org/content/331/6023/1439.abstract
29 Direct interaction of RNA polymerase II and mediator required for transcription in vivo.
Soutourina J. et al. (2011). Science 331:1451-1454.
http://www.sciencemag.org/content/331/6023/1451.abstract
28 Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.
Keunen O et al. (2011). PNAS 108: 3749-3754.
http://www.pnas.org/content/108/9/3749.abstract
27 Messenger RNA has received little attention as a potential therapeutic agent. Kormann et al. show that intramuscular injection of chemically modified erythropoietin mRNA substantially increases the hematocrit in mice and demonstrate the curative potential of pulmonary mRNA delivery in a mouse model of congenital surfactant protein B deficiency. Kormann SD et al. (2011). Nature Biotechnology 29: 154–157
http://www.nature.com/nbt/journal/v29/n2/abs/nbt.1733.html
26 miR-34a regulates progenitor and metastatic properties of prostate cancer cells, and they identify CD44 as a relevant target of the microRNA. The inhibition of metastasis observed after systemic delivery of miR-34a suggests that it could be used as a potential therapeutic agent in prostate cancer. Liu et al. (2011). Nature Medicine 17:211–215
http://www.nature.com/nm/journal/v17/n2/abs/nm.2284.html
25 Identification of aneuploidy-selective antiproliferation compounds.
Tang Y-C, et al. (2011). Cell 144:499-512.
http://www.cell.com/abstract/S0092-8674(11)00056-0
|
